Capital Analysts LLC’s Avita Medical RCEL Stock Holding History

Capital Analysts LLC’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Hold	652	–	–	﹤0.01%	1465
2025 Q4	$2K	Hold	652	–	–	﹤0.01%	1422
2025 Q3	$3K	Hold	652	–	–	﹤0.01%	1352
2025 Q2	$3K	Hold	652	–	–	﹤0.01%	1302
2025 Q1	$5K	Hold	652	–	–	﹤0.01%	1230
2024 Q4	$8K	Hold	652	–	–	﹤0.01%	1106
2024 Q3	$7K	Hold	652	–	–	﹤0.01%	1090
2024 Q2	$5K	Hold	652	–	–	﹤0.01%	1048
2024 Q1	$10K	Hold	652	–	–	﹤0.01%	925
2023 Q4	$9K	Hold	652	–	–	﹤0.01%	910
2023 Q3	$10K	Hold	652	–	–	﹤0.01%	884
2023 Q2	$11K	Hold	652	–	–	﹤0.01%	810
2023 Q1	$9K	Hold	652	–	–	﹤0.01%	817
2022 Q4	$4K	Hold	652	–	–	﹤0.01%	939
2022 Q3	$3K	Hold	652	–	–	﹤0.01%	957
2022 Q2	$3K	Hold	652	–	–	﹤0.01%	925
2022 Q1	$6K	Hold	652	–	–	﹤0.01%	805
2021 Q4	$8K	Hold	652	–	–	﹤0.01%	840
2021 Q3	$12K	Hold	652	–	–	﹤0.01%	772
2021 Q2	$13K	Hold	652	–	–	﹤0.01%	714
2021 Q1	$13K	Buy	+652	New	+$15.2K	﹤0.01%	764

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Analysts LLC's RCEL Position: Q1 2026 in Review

Capital Analysts LLC held its Avita Medical (RCEL) position steady in Q1 2026 at 652 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Capital Analysts LLC first reported a position in RCEL in Q1 2021 and has held it in 21 quarters since. The position peaked at $13K in Q2 2021. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

Capital Analysts LLC held 652 shares of Avita Medical worth $2K as of Q1 2026.
Capital Analysts LLC left its Avita Medical share count unchanged in Q1 2026.
Avita Medical made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #1465 holding.
Capital Analysts LLC first reported a position in Avita Medical in Q1 2021 and has held it in 21 quarters since.
Capital Analysts LLC's Avita Medical position peaked at $13K in Q2 2021.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.